Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats

Journal of Neurochemistry

Volumn 115, Issue 5, 2010, Pages 1266-1276

  Suofu, Yalikun ^a   Clark, Joseph ^a   Broderick, Joseph ^a   Wagner, Kenneth R ^a   Tomsick, Thomas ^b   Sa, Yalian ^a   Lu, Aigang ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Brain damage; Cerebral ischemia; Matrix metalloproteinase; Neuroprotection; Peroxynitrite

Indexed keywords

COLLAGEN TYPE 4; FERRIC 5,10,15,20 TETRAKIS (2,4,6 TRIMETHYL 3,5 DISULFONATOPHENYL) PORPHYRIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; METALLOPORPHYRIN; PEROXYNITRITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN NERVE CELL; CATALYST; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; BASEMENT MEMBRANE; CEREBRAL CORTEX; CEREBRAL INFARCTION; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FERRIC COMPOUNDS; HEMATINICS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; METALLOPORPHYRINS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; REPERFUSION INJURY; TIME FACTORS;

RATTUS;

EID: 78149235340     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.07026.x     Document Type: Article

References (41)

1. Aoki T., Sumii T., Mori T., Wang X. and Lo E. H. (2002) Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke 33, 2711-2717.
2. Asahi M., Asahi K., Jung J. C., Del Zoppo G. J., Fini M. E. and Lo E. H. (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20, 1681-1689.
3. Beckman J. S. and Koppenol W. H. (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271, C1424-C1437.
4. Chen Z. L. and Strickland S. (1997) Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91, 917-925.
5. Cunningham L. A., Wetzel M. and Rosenberg G. A. (2005) Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50, 329-339.
6. Cuzzocrea S., Misko T. P., Costantino G., Mazzon E., Micali A., Caputi A. P., Macarthur H. and Salvemini D. (2000) Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J. 14, 1061-1072.
7. Cuzzocrea S., Riley D. P., Caputi A. P. and Salvemini D. (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 53, 135-159.
8. Dirnagl U., Lindauer U., Them A., Schreiber S., Pfister H. W., Koedel U., Reszka R., Freyer D. and Villringer A. (1995) Global cerebral ischemia in the rat: online monitoring of oxygen free radical production using chemiluminescence in vivo. J. Cereb. Blood Flow Metab. 15, 929-940.
9. Eliasson M. J., Huang Z., Ferrante R. J., Sasamata M., Molliver M. E., Snyder S. H. and Moskowitz M. A. (1999) Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J. Neurosci. 19, 5910-5918.
10. Frears E. R., Zhang Z., Blake D. R., O'Connell J. P. and Winyard P. G. (1996) Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett. 381, 21-24.
11. Gasche Y., Fujimura M., Morita-Fujimura Y., Copin J. C., Kawase M., Massengale J. and Chan P. H. (1999) Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab. 19, 1020-1028.
12. Gasche Y., Copin J. C., Sugawara T., Fujimura M. and Chan P. H. (2001) Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 21, 1393-1400.
13. Gobbel G. T., Chan T. Y. and Chan P. H. (1997) Nitric oxide- and superoxide-mediated toxicity in cerebral endothelial cells. J. Pharmacol. Exp. Ther. 282, 1600-1607.
14. Gua Z., Kaul M., Yan B., Kridel S. J., Cui J., Strongin A., Smith J. W., Liddington R. C. and Lipton S. A. (2002) S-Nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297, 1186-1190.
15. Gursoyo-Ozdemir Y., Can A. and Dalkara T. (2004) Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35, 1449-1453.
16. Gursoy-Ozdemir Y., Bolay H., Saribas O. and Dalkara T. (2000) Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia. Stroke 31, 1974-1980.
17. Heo J. H., Lucero J., Abumiya T., Koziol J. A., Copeland B. R. and Del Zoppo G. J. (1999) Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19, 624-633.
18. Jourquin J., Tremblay E., Decanis N., Charton G., Hanessian S., Chollet A. M., Le Diguardher T., Khrestchatisky M. and Rivera S. (2003) Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur. J. Neurosci. 18, 1507-1517.
19. Jung J. E., Kim G. S., Narasimhan P., Song Y. S. and Chan P. H. (2009) Regulation of Mn-superoxide dismutase activity and neuroprotection by STAT3 in mice after cerebral ischemia. J. Neurosci. 29, 7003-7014.
20. Kidd G. A., Hong H., Majid A., Kaufman D. I. and Chen A. F. (2005) Inhibition of brain GTP cyclohydrolase I and tetrahydrobiopterin attenuates cerebral infarction via reducing inducible NO synthase and peroxynitrite in ischemic stroke. Stroke 36, 2705-2711.
21. Kumura E., Yoshimine T., Iwatsuki K. I., Yamanaka K., Tanaka S., Hayakawa T., Shiga T. and Kosaka H. (1996) Generation of nitric oxide and superoxide during reperfusion after focal cerebral ischemia in rats. Am. J. Physiol. 270, C748-C752.
22. Lin B. and Ginsberg M. D. (2000) Quantitative assessment of the normal cerebral microvasculature by endothelial barrier antigen (EBA) immunohistochemistry: application to focal cerebral ischemia. Brain Res. 865, 237-244.
23. Lu A., Clark J. F., Broderick J. P., Pyne-Geithman G. J., Wagner K. R., Ran R., Khatri P., Tomsick T. and Sharp F. R. (2008) Reperfusion activates metalloproteinases that contribute to neurovascular injury. Exp. Neurol. 210, 549-559.
24. Lu A., Clark J. F., Broderick J. P., Pyne-Geithman G. J., Wagner K. R., Khatri P., Tomsick T. and Sharp F. R. (2009) Mechanical reperfusion is associated with post-ischemic hemorrhage in rat brain. Exp. Neurol. 216, 407-412.
25. Marla S. S., Lee J. and Groves J. T. (1997) Peroxynitrite rapidly permeates phospholipid membranes. Proc. Natl Acad. Sci. USA 94, 14243-14248.
26. Migita K., Maeda Y., Abiru S., Komori A., Yokoyama T., Takii Y., Nakamura M., Yatsuhashi H., Eguchi K. and Ishibashi H. (2005) Peroxynitrite-mediated matrix metalloproteinase-2 activation in human hepatic stellate cells. FEBS Lett. 579, 3119-3125.
27. Mun-Bryce S. and Rosenberg G. A. (1998) Matrix metalloproteinases in cerebrovascular disease. J. Cereb. Blood Flow Metab. 18, 1163-1172.
28. Murphy G., Willenbrock F., Crabbe T., O'Shea M., Ward R., Atkinson S., O'Connell J. and Docherty A. (1994) Regulation of matrix metalloproteinase activity. Ann. N Y Acad. Sci. 732, 31-41.
29. Naidu B. V., Fraga C., Salzman A. L., Szabo C., Verrier E. D. and Mulligan M. S. (2003) Critical role of reactive nitrogen species in lung ischemia-reperfusion injury. J. Heart Lung Transplant. 22, 784-793.
30. Okamoto T., Akaike T., Nagano T., Miyajima S., Suga M., Ando M., Ichimori K. and Maeda H. (1997) Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch. Biochem. Biophys. 342, 261-274.
31. Okamoto T., Akaike T., Sawa T., Miyamoto Y., Van Der Vliet A. and Maeda H. (2001) Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J. Biol. Chem. 276, 29596-29602.
32. Rajagopalan S., Meng X. P., Ramasamy S., Harrison D. G. and Galis Z. S. (1996) Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98, 2572-2579.
33. Rosell A. and Lo E. H. (2008) Multiphasic roles for matrix metalloproteinases after stroke. Curr. Opin. Pharmacol. 8, 82-89.
34. Salvemini D., Wang Z. Q., Stern M. K., Currie M. G. and Misko T. P. (1998) Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc. Natl Acad. Sci. USA 95, 2659-2663.
35. Stefanutti G., Pierro A., Smith V. V., Klein N. J. and Eaton S. (2007) Peroxynitrite decomposition catalyst FeTMPyP provides partial protection against intestinal ischemia and reperfusion injury in infant rats. Pediatr. Res. 62, 43-48.
36. Thiyagarajan M., Kaul C. L. and Sharma S. S. (2004) Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats. Br. J. Pharmacol. 142, 899-911.
37. Viappiani S., Nicolescu A. C., Holt A., Sawicki G., Crawford B. D., Leon H., Van Mulligen T. and Schulz R. (2009) Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione. Biochem. Pharmacol. 77, 826-834.
38. Wang W., Sawicki G. and Schulz R. (2002) Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc. Res. 53, 165-174.
39. Xu J., He L., Ahmed S. H., Chen S. W., Goldberg M. P., Beckman J. S. and Hsu C. Y. (2000) Oxygen-glucose deprivation induces inducible nitric oxide synthase and nitrotyrosine expression in cerebral endothelial cells. Stroke 31, 1744-1751.
40. Yang Y., Ke-Zhou L., Ning G. M., Wang M. L. and Zheng X. X. (2008) Dynamics of nitric oxide and peroxynitrite during global brain ischemia/reperfusion in rat hippocampus: NO-sensor measurement and modeling study. Neurochem. Res. 33, 73-80.
41. Zhang L., Zhang Z. G., Liu X., Hozeska A., Stagliano N., Riordan W., Lu M. and Chopp M. (2006) Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator. Thromb. Haemost. 95, 166-173.